Reviva Pharmaceuticals Holdings, Inc.
RVPH- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001742927
No open-market purchases or sales by Reviva Pharmaceuticals Holdings, Inc. insiders were filed in the last 90 days; 5 institutions reported holding it in 13F filings for Q2 2026, worth $3.67K in total; no superinvestor holds it.
13F holders, Q1 2024
Institutional positions in Reviva Pharmaceuticals Holdings, Inc. as of Mar 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 28
- −8 vs. Q4 2023
- Shares held
- 5.57M
- +307.5K (+5.8%) vs. Q4 2023
- Total value
- $21.0M
- −$6.11M (−22.5%) vs. Q4 2023
- New holders
- 3
- 12 more added
- Sold out
- 11
- 5 more reduced
Compare with Q4 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting RVPH on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 5 | $3.67K |
| Q1 2026 | 35 | $2.13M |
| Q4 2025 | 48 | $3.17M |
| Q3 2025 | 42 | $3.52M |
| Q2 2025 | 46 | $5.44M |
| Q1 2025 | 49 | $6.95M |
| Q4 2024 | 42 | $14.0M |
| Q3 2024 | 33 | $14.3M |
| Q2 2024 | 31 | $8.75M |
| Q1 2024 | 28 | $21.0M |
| Q4 2023 | 36 | $27.1M |
| Q3 2023 | 24 | $13.0M |
| Q2 2023 | 23 | $15.5M |
| Q1 2023 | 22 | $5.76M |
| Q4 2022 | 23 | $5.54M |
| Q3 2022 | 19 | $1.65M |
| Q2 2022 | 13 | $2.05M |
| Q1 2022 | 16 | $4.68M |
| Q4 2021 | 14 | $7.54M |
| Q3 2021 | 12 | $10.5M |
| Q2 2021 | 12 | $12.8M |
| Q1 2021 | 8 | $3.37M |
Institutions, Q1 2024
Shares, value and share of portfolio for each institution holding Reviva Pharmaceuticals Holdings, Inc.; share changes are against Q4 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Wells Fargo & Company | 175 | $662 | 0.00% | +36+25.9% | Added |
| Archer Investment Corp | 500 | $1.89K | 0.00% | 00.0% | Unchanged |
| Cutler Group LP | 3,043 | $11.0K | 0.01% | 00.0% | Unchanged |
| Wolverine Asset Management LLC | 3,375 | $12.8K | 0.00% | −1,274−27.4% | Reduced |
| Morgan Stanley | 5,621 | $21.2K | 0.00% | +853+17.9% | Added |
| UBS Group AG | 8,099 | $30.6K | 0.00% | +8,099 | New |
| Northwestern Mutual Wealth Management Co | 9,299 | $35.1K | 0.00% | 00.0% | Unchanged |
| BluePointe Capital Management, LLC | 10,378 | $39.2K | 0.03% | 00.0% | Unchanged |
| NRI Wealth Management LC | 12,380 | $46.8K | 0.04% | 00.0% | Unchanged |
| Vontobel Holding Ltd. | 14,000 | $52.9K | 0.00% | 00.0% | Unchanged |
| Qube Research & Technologies Ltd | 21,513 | $81.3K | 0.00% | −13,851−39.2% | Reduced |
| Bank of America Corp | 21,929 | $82.9K | 0.00% | +6,943+46.3% | Added |
| Jane Street Group, LLC | 30,090 | $113.7K | 0.00% | +999+3.4% | Added |
| Marshall Wace, LLP | 34,868 | $131.8K | 0.00% | −4,232−10.8% | Reduced |
| JPMorgan Chase & Co | 38,663 | $146.1K | 0.00% | +37,746+4,116.2% | Added |
| Northern Trust Corp | 50,448 | $190.7K | 0.00% | +10,224+25.4% | Added |
| State Street Corp | 63,200 | $238.9K | 0.00% | −2,300−3.5% | Reduced |
| BlackRock Inc. | 91,861 | $347.2K | 0.00% | −377−0.4% | Reduced |
| EMC Capital Management | 123,915 | $411.0K | 0.25% | 00.0% | Unchanged |
| Polar Asset Management Partners Inc. | 154,800 | $585.1K | 0.02% | 00.0% | Unchanged |
| Colony Group, LLC | 171,000 | $646.0K | 0.01% | +50,000+41.3% | Added |
| Geode Capital Management, LLC | 220,117 | $832.2K | 0.00% | +41,311+23.1% | Added |
| Susquehanna International Group, LLP | 242,667 | $917.3K | 0.00% | +36,955+18.0% | Added |
| Parkman Healthcare Partners LLC | 503,854 | $1.90M | 0.23% | +503,854 | New |
| Schonfeld Strategic Advisors LLC | 826,600 | $3.12M | 0.02% | +826,600 | New |
| Millennium Management LLC | 854,597 | $3.23M | 0.00% | +52,691+6.6% | Added |
| Vanguard Group Inc | 1,001,836 | $3.79M | 0.00% | +26,854+2.8% | Added |
| Woodline Partners LP | 1,055,009 | $3.99M | 0.04% | +934,609+776.3% | Added |
| Armistice Capital, LLC | 0 | $0 | 0.00% | −1,764,000−100.0% | Sold out |
| Rosalind Advisors, Inc. | 0 | $0 | 0.00% | −196,300−100.0% | Sold out |
| Man Group plc | 0 | $0 | 0.00% | −49,196−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −45,255−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −45,212−100.0% | Sold out |
| Two Sigma Investments, LP | 0 | $0 | 0.00% | −41,599−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −38,043−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −15,234−100.0% | Sold out |
| Integrated Wealth Concepts LLC | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |
| Belvedere Trading LLC | 0 | $0 | 0.00% | −3,320−100.0% | Sold out |
| Royal Bank of Canada | 0 | $0 | 0.00% | −39−100.0% | Sold out |